Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Gains from Sales and Divestitures (2021 - 2025)

Tivic Health Systems has reported Gains from Sales and Divestitures over the past 4 years, most recently at $111.0 for Q3 2025.

  • Quarterly results put Gains from Sales and Divestitures at $111.0 for Q3 2025, down 97.04% from a year ago — trailing twelve months through Sep 2025 was $111.0 (down 97.04% YoY), and the annual figure for FY2024 was $331.0, changed.
  • Gains from Sales and Divestitures for Q3 2025 was $111.0 at Tivic Health Systems, roughly flat from $111.0 in the prior quarter.
  • Over the last five years, Gains from Sales and Divestitures for TIVC hit a ceiling of $11719.0 in Q4 2021 and a floor of $71.0 in Q4 2022.
  • Median Gains from Sales and Divestitures over the past 4 years was $1875.0 (2024), compared with a mean of $3561.1.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 99.39% in 2022 and later plummeted 94.08% in 2025.
  • Tivic Health Systems' Gains from Sales and Divestitures stood at $11719.0 in 2021, then plummeted by 99.39% to $71.0 in 2022, then surged by 366.2% to $331.0 in 2024, then plummeted by 66.47% to $111.0 in 2025.
  • The last three reported values for Gains from Sales and Divestitures were $111.0 (Q3 2025), $111.0 (Q2 2025), and $111.0 (Q1 2025) per Business Quant data.